The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metabolic complete responses (mCR) in patients with metastatic uveal melanoma (mUM) treated with image-guided injection (IGI) of PV-10.
 
Krysta McVay
Research Funding - Bristol-Myers Squibb (Inst); Nektar (Inst); Novartis (Inst); Provectus Biopharmaceuticals (Inst)
 
Rahul Sheth
Consulting or Advisory Role - Medtronic; TriSalus Life Sciences
Research Funding - Boston Scientific
 
Ravi Murthy
Stock and Other Ownership Interests - Daedalus Interventional, LLC
Consulting or Advisory Role - Cura Therapeutics
 
Dan S. Gombos
Honoraria - Bristol-Myers Squibb/Medarex; Putnam Associates
Consulting or Advisory Role - Abbvie
Travel, Accommodations, Expenses - Abbvie
Other Relationship - 3T Ophthalmics; Aura Biosciences; Castle Biosciences
 
Brett W. Carter
No Relationships to Disclose
 
Priya Bhosale
No Relationships to Disclose
 
Nourel hoda Tahon
No Relationships to Disclose
 
Gener C Balmes
Research Funding - Boston Scientific (Inst); Dragonfly Therapeutics (Inst); Merck (Inst); Parker Institute for Cancer Immunotherapy (Inst); Provectus Biopharmaceuticals (Inst)
 
Ysabell M Coz
Research Funding - GlaxoSmithKline (Inst); InxMed (Inst); Kartos Therapeutics (Inst); Merck (Inst); Nektar (Inst); Provectus Biopharmaceuticals (Inst); Syntrix Biosystems (Inst)
 
Edwina Washington
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); InxMed (Inst); Kartos Therapeutics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Provectus Biopharmaceuticals (Inst); Roche (Inst); Syntrix Biosystems (Inst)
 
Dominic Rodrigues
Employment - Mednax/Pediatrix (I)
Leadership - Provectus Biopharmaceuticals
Stock and Other Ownership Interests - Mednax/Pediatrix (I); Provectus Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - Provectus Biopharmaceuticals
 
Eric Andrew Wachter
Employment - Provectus Biopharmaceuticals
Leadership - Provectus Biopharmaceuticals
Stock and Other Ownership Interests - Provectus Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - Named inventor on one or more US or international patents assigned to Provectus Biopharmaceuticals
 
Sapna Pradyuman Patel
Honoraria - Delcath Systems; Immunocore; Merck
Consulting or Advisory Role - Castle Biosciences; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Lyvgen Biopharma (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); Seagen (Inst); Syntrix Biosystems (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - TriSalus Life Sciences
Other Relationship - Immunocore